Suppr超能文献

胎膜早破后产前使用糖皮质激素的有效性。

Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes.

作者信息

Vermillion S T, Soper D E, Bland M L, Newman R B

机构信息

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

出版信息

Am J Obstet Gynecol. 2000 Oct;183(4):925-9. doi: 10.1067/mob.2000.108845.

Abstract

OBJECTIVE

This study was undertaken to determine the effect of antenatal betamethasone administration on the incidences of respiratory distress syndrome, intraventricular hemorrhage, and perinatal infectious morbidity in the setting of preterm premature rupture of membranes.

STUDY DESIGN

We performed a nonconcurrent prospective analysis of women with singleton pregnancies who were delivered between 24 and 32 weeks' gestation after preterm premature rupture of membranes. Patients were subdivided into 2 groups according to betamethasone exposure: (1) none (control group) and (2) two 12-mg doses in a 24-hour interval on admission (single-course group). Patients who received >2 doses of betamethasone were excluded. All patients received broad-spectrum prophylactic antibiotics. Data were analyzed with the Student t test, the chi(2) test, and the Fisher exact test. Multiple logistic regression analyses incorporated multiple variables considered risk factors for respiratory distress syndrome and intraventricular hemorrhage. P <.05 for all 2-tailed tests was considered significant.

RESULTS

A total of 362 patients were included, with 203 in the control group and 159 in the single-course group. Patients in these groups were delivered at 31.0 +/- 3.0 and 30.2 +/- 2.7 (mean +/- SD) weeks' gestation, respectively. The groups were similar with respect to selected demographic characteristics, latency until delivery, mode of delivery, birth weight, and maternal group B streptococcal colonization status. Univariate analysis demonstrated significant decreases in the frequencies of both respiratory distress syndrome (odds ratio, 0.31; 95% confidence interval, 0.2-0.5) and grade III/IV intraventricular hemorrhage (odds ratio, 0.14; 95% confidence interval, 0.1-0.6) in the single-course group. The frequencies of early neonatal sepsis, chorioamnionitis, endometritis, and neonatal death were similar between groups. Multiple logistic regression analyses determined that a single course of betamethasone was independently associated with reductions in the frequencies of both respiratory distress syndrome (odds ratio, 0.16; 95% confidence interval, 0.1-0.4) and grade III/IV intraventricular hemorrhage (odds ratio, 0.18; 95% confidence interval, 0.1-0.4).

CONCLUSIONS

A single course of betamethasone administered antenatally to patients with preterm premature rupture of membranes was associated with decreases in the frequencies of both respiratory distress syndrome and advanced grades of intraventricular hemorrhage without any increase in perinatal infectious morbidity.

摘要

目的

本研究旨在确定产前给予倍他米松对胎膜早破早产情况下呼吸窘迫综合征、脑室内出血及围产期感染性疾病发病率的影响。

研究设计

我们对单胎妊娠、孕24至32周胎膜早破后分娩的妇女进行了非同期前瞻性分析。根据倍他米松暴露情况将患者分为两组:(1)未暴露组(对照组)和(2)入院时24小时内给予两剂12毫克剂量组(单疗程组)。接受超过2剂倍他米松的患者被排除。所有患者均接受广谱预防性抗生素治疗。数据采用Student t检验、卡方检验和Fisher精确检验进行分析。多因素逻辑回归分析纳入了多个被认为是呼吸窘迫综合征和脑室内出血危险因素的变量。所有双侧检验P <.05被认为具有统计学意义。

结果

共纳入362例患者,对照组203例,单疗程组159例。这些组的患者分别在孕31.0±3.0周和30.2±2.7周(均值±标准差)分娩。两组在选定的人口统计学特征、分娩延迟时间、分娩方式、出生体重及孕妇B族链球菌定植状况方面相似。单因素分析显示,单疗程组呼吸窘迫综合征(优势比,0.31;95%置信区间,0.2 - 0.5)和III/IV级脑室内出血(优势比,0.14;95%置信区间,0.1 - 0.6)的发生率均显著降低。两组早期新生儿败血症、绒毛膜羊膜炎、子宫内膜炎及新生儿死亡的发生率相似。多因素逻辑回归分析确定,单疗程倍他米松与呼吸窘迫综合征(优势比,0.16;95%置信区间,0.1 - 0.4)和III/IV级脑室内出血(优势比,0.18;95%置信区间,0.1 - 0.4)发生率的降低独立相关。

结论

对胎膜早破早产患者产前给予单疗程倍他米松与呼吸窘迫综合征和高级别脑室内出血发生率的降低相关,且围产期感染性疾病发病率未增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验